Hello, everyone, and nice to see you again after a long holiday break. We hope the respite was relaxing and invigorating, and the new year has gotten off to a good start. Now, of course, the time has come to resume the usual routine of meetings, deadlines, and the like. You knew this would happen, yes? Before we continue, though, we are sorry to report that one of our official mascots, Rosie the Beagle, passed away the other day. No longer will she snooze in a nearby corner or, displaying uncanny timing, bark vociferously during our phone calls. Rest in peace, little one. Meanwhile, here are some tidbits to get you going. Hope your day goes well and please do keep in touch …

With the new year, drug makers will have to pay far more into Medicare — nearly $12 billion over the next decade — in a policy change that the powerful industry lobbying group did not see coming, STAT explains. The effort to combat the higher payments illustrated how flat-footed PhRMA was caught by the policy, how it spun together multiple lobbying strategies to advance its “fix,” and how close it came to getting its way. “This might well be the biggest political loss that PhRMA has suffered in a decade,” says Daniel Carpenter, a professor of government at Harvard.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy